Naloxone Hydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

30 Suppliers, 13 USDMF, 11 CEP/COS, 1 JDMF, 3 EU WC, 2 KDMF, 19 NDC API, 19 Listed Suppliers

DEVELOPMENTS

51 Drug(s) in Development

51 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

8 Suppliers

8 Suppliers

DOSSIERs // Finished Dosage Forms

260 Dossiers, 157 FDA Orange Book, 33 Europe, 11 Canada, 16 Australia, 7 South Africa, 36 Listed Dossiers

DRUG PRODUCT COMPOSITION

FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE, FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE, FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.4MG/0.4ML (0.4MG/0.4ML), TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 2MG/0.4ML (2MG/0.4ML), FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE, FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 37 Kerry, 23 Roquette, 17 SPI Pharma, 16 BASF, 13 Gangwal Healthcare, 13 Microlex e.U, 10 Corel Pharma Chem, 10 Sigachi Industries, 10 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 Seppic, 7 Gangwal Chemicals, 6 DFE Pharma, 6 Lonza Capsugel, 5 Ideal Cures Pvt Ltd, 4 Prachin Chemical, 4 Ingredion Pharma Solutions, 4 Rochem International Inc, 3 Kima Chemical, 3 Vasa Pharmachem, 2 Boai NKY Pharmaceuticals Ltd, 2 Nomisma Healthcare, 2 Nanjing Well Pharmaceutical, 2 Seqens, 2 Finar, 2 The Dow Chemical Company, 2 Jai Radhe Sales, 2 Pharmatrans-Sanaq, 1 Pfanstiehl, 1 Alcedo Pharmachem, 1 Minakem, 1 Zhejiang Huakang Pharmaceutical, 1 Ulanqab Kema New Material, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Bioplus Life Sciences, 1 Shijiazhuang Huaxu Pharmaceutical, 1 ACG Worldwide, 1 Shanghai Welltone Material Technology Co., Ltd, 1 NEWEDGE Overseas, 1 Pharm-RX Chemical, 1 Qualicaps, 1 Chynops Pharma, 1 DKSH

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 36 Direct Compression, 25 Controlled & Modified Release, 25 Taste Masking, 23 Thickeners and Stabilizers, 22 Granulation, 21 Disintegrants & Superdisintegrants, 19 Lubricants & Glidants, 18 Chewable & Orodispersible Aids, 16 Co-Processed Excipients, 11 Parenteral, 8 Topical, 8 Solubilizers, 7 Film Formers & Plasticizers, 6 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 3 Emulsifying Agents, 3 Rheology Modifiers, 2 Coloring Agents

GLOBAL SALES INFORMATION

21 US Medicaid Prescriptions, 26 Finished Drug Prices

MARKET PLACE

14 APIs, 10 DOSSIERS // FDF

PATENTS

183 US Patents, 1 US Exclusivities

ANALYTICAL SOLUTION(s)

3 EDQM Standards, 1 USP Standards, 5 Other Ref. Standards

DIGITAL CONTENT

3 Data Compilation & Company Tracker #PharmaFlow, 223 News

Information, Expiry, & Status of FDA Orange Book Exclusivities covering Naloxone Hydrochloride

Naloxone Hydrochloride

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

30 Suppliers

13 USDMF

11 CEP/COS

1 JDMF

3 EU WC

2 KDMF

19 NDC API

19 Listed Suppliers

DEVELOPMENTS

51 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

8 Suppliers

DOSSIERs // Finished Dosage Forms

260 Dossiers

157 FDA Orange Book

33 Europe

11 Canada

16 Australia

7 South Africa

36 Listed Dossiers

DRUG PRODUCT COMPOSITION

FILM;BUCCAL - EQ 2.1MG BASE;EQ 0.3MG BASE

FILM;BUCCAL - EQ 4.2MG BASE;EQ 0.7MG BASE

FILM;BUCCAL - EQ 6.3MG BASE;EQ 1MG BASE

SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.4MG/0.4ML (0.4MG/0.4ML)

TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 2MG/0.4ML (2MG/0.4ML)

FILM;BUCCAL, SUBLINGUAL - EQ 12MG BASE;EQ 3MG BASE

FILM;BUCCAL, SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE

FILM;BUCCAL, SUBLINGUAL - EQ 4MG BASE;EQ 1MG BASE

FILM;BUCCAL, SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers

37 Kerry

23 Roquette

17 SPI Pharma

16 BASF

13 Gangwal Healthcare

13 Microlex e.U

10 Corel Pharma Chem

10 Sigachi Industries

10 Actylis

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 Seppic

7 Gangwal Chemicals

6 DFE Pharma

6 Lonza Capsugel

5 Ideal Cures Pvt Ltd

4 Prachin Chemical

4 Ingredion Pharma Solutions

4 Rochem International Inc

3 Kima Chemical

3 Vasa Pharmachem

2 Boai NKY Pharmaceuticals Ltd

2 Nomisma Healthcare

2 Nanjing Well Pharmaceutical

2 Seqens

2 Finar

2 The Dow Chemical Company

2 Jai Radhe Sales

2 Pharmatrans-Sanaq

1 Pfanstiehl

1 Alcedo Pharmachem

1 Minakem

1 Zhejiang Huakang Pharmaceutical

1 Ulanqab Kema New Material

1 Qianhao Chemical (Hebei) Co., Ltd

TABLET;SUBLINGUAL - EQ 2MG BASE;EQ 0.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;SUBLINGUAL - EQ 8MG BASE;EQ 2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons